Safety and efficacy of sirolimus as immunosuppressive. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Antilymphocyte Serum T-Lymphocytes Kidney T-Lymphocytes, Regulatory Cells, Cultured Spleen Chyle Lymphocytes Dendritic Cells CD4-Positive T-Lymphocytes Myeloid Cells Cell Line, Tumor Immune System CD8-Positive T-Lymphocytes Transplants Macrophages Cell Line B-Lymphocytes Leukocytes, Mononuclear

Organisms9

Mice, Inbred BALB C Mice, Inbred C57BL Rats, Inbred Lew Citrus paradisi Swine Rabbits Rats, Sprague-Dawley Mice, Inbred C3H Rats, Wistar

Diseases41

Lymphangioleiomyomatosis Angiomyolipoma Anemia, Aplastic Recurrence Postoperative Complications Coronary Restenosis Lymphangiomyoma Disease Models, Animal Graft vs Host Disease Neoplasms Chronic Disease Acute Disease Opportunistic Infections Drug-Related Side Effects and Adverse Reactions Infection Proteinuria Autoimmune Diseases Kidney Diseases Disease Progression Renal Insufficiency Kidney Failure, Chronic Nephrotic Syndrome Thrombotic Microangiopathies Uveitis Lupus Erythematosus, Systemic Scleritis Skin Neoplasms Liver Diseases Inflammation Glomerulonephritis, Membranous Polycystic Kidney, Autosomal Dominant Hypersensitivity, Delayed Rheumatic Diseases Cadaver Vasculitis Diabetes Mellitus, Type 1 Glomerulosclerosis, Focal Segmental Oral Ulcer Tuberous Sclerosis Lymphoproliferative Disorders Wegener Granulomatosis

Chemicals and Drugs79

Sirolimus Immunosuppressive Agents Tacrolimus Cyclosporine Mycophenolic Acid Calcineurin Azathioprine Antilymphocyte Serum Cyclosporins Prednisolone Polyenes TOR Serine-Threonine Kinases Antibodies, Monoclonal Adrenal Cortex Hormones Creatinine Glucocorticoids Methylprednisolone Anti-Inflammatory Agents Prednisone Steroids Cyclophosphamide Antibodies, Monoclonal, Humanized Interleukin-10 Drug Combinations Antibiotics, Antineoplastic Antineoplastic Agents Cytokines Indoleamine-Pyrrole 2,3,-Dioxygenase Amino Acid Isomerases Methotrexate Cardiovascular Agents Interleukin-2 Propylene Glycols Immunologic Factors Immunoglobulin G Drug Implants Paclitaxel Interferon-gamma Tubulin Modulators Coated Materials, Biocompatible Immunoconjugates Anti-Bacterial Agents Isoxazoles Forkhead Transcription Factors Interleukin-2 Receptor alpha Subunit Peptidylprolyl Isomerase Oxaloacetic Acid Placebos Antibodies, Neoplasm Tacrolimus Binding Proteins IMP Dehydrogenase Tumor Necrosis Factor-alpha Benzenesulfonates Antiviral Agents Antirheumatic Agents Antibodies, Monoclonal, Murine-Derived Muromonab-CD3 Biological Markers Phenylurea Compounds Recombinant Proteins Cytochrome P-450 CYP3A Acetic Anhydrides Adjuvants, Immunologic Dexamethasone Antigens, CD Anti-Inflammatory Agents, Non-Steroidal Antigens, CD3 Enzyme Inhibitors Antifungal Agents Suppressor Factors, Immunologic Transforming Growth Factor beta Phytohemagglutinins Drug Carriers Polyethylene Glycols Ketoconazole Pyrroles Receptors, Interleukin-2 Pyridines RNA, Messenger

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Kidney Transplantation Immunosuppression Treatment Outcome Drug Therapy, Combination Transplantation, Homologous Liver Transplantation Drug Substitution Follow-Up Studies Retrospective Studies Double-Blind Method Transplantation Heart Transplantation Islets of Langerhans Transplantation Drug Administration Schedule Prospective Studies Drug Monitoring Lymphocyte Activation Administration, Oral Equipment Safety Organ Transplantation Pilot Projects Disease Models, Animal Injections, Intraocular Biopsy Drug-Eluting Stents Clinical Trials as Topic Randomized Controlled Trials as Topic Glomerular Filtration Rate Skin Transplantation Stents Flow Cytometry Risk Factors Survival Rate Kidney Function Tests Lymphocyte Culture Test, Mixed Transplantation Conditioning Feasibility Studies Kaplan-Meier Estimate Survival Analysis Hematopoietic Stem Cell Transplantation Risk Assessment Pancreas Transplantation Retreatment Antineoplastic Combined Chemotherapy Protocols Incidence Drug Delivery Systems Fluorescence Polarization Immunoassay Immunotherapy Bone Marrow Transplantation Severity of Illness Index Plasmapheresis Drug Evaluation, Preclinical Placebos Area Under Curve Infusions, Intravenous Models, Animal Cohort Studies Administration, Topical Absorbable Implants Enzyme-Linked Immunosorbent Assay Product Surveillance, Postmarketing Injections, Intravenous Remission Induction Disease-Free Survival Lung Transplantation Fatal Outcome Prognosis Pulse Therapy, Drug Coronary Angiography Chromatography, High Pressure Liquid Drug Carriers Angioplasty, Balloon, Coronary Injections, Subcutaneous Postoperative Care

Phenomena and Processes21

Graft Rejection Graft Survival Time Factors Immune Tolerance Dose-Response Relationship, Drug Lymphocyte Activation Immunocompromised Host Cell Proliferation Drug Interactions Glomerular Filtration Rate Transplantation Immunology Transplantation Tolerance Antibody Formation Tumor Escape Drug Synergism Immunity, Cellular Apoptosis Signal Transduction Area Under Curve Cell Survival Immunocompetence

Anthropology, Education, Sociology and Social Phenomena1

National Institute for Occupational Safety and Health (U.S.)

Technology, Industry, Agriculture3

Food Safety Coated Materials, Biocompatible Polyethylene Glycols

Information Science4

Survival Rate Incidence Fatal Outcome Molecular Sequence Data

Named Groups3

Tissue Donors Living Donors Unrelated Donors

Health Care32

Safety Treatment Outcome Safety Management Patient Safety Drug Substitution Follow-Up Studies Retrospective Studies Double-Blind Method Prospective Studies Food Safety Pilot Projects Consumer Product Safety Clinical Trials as Topic Randomized Controlled Trials as Topic Risk Factors Survival Rate Feasibility Studies Medical Errors Kaplan-Meier Estimate Survival Analysis Risk Assessment Incidence Severity of Illness Index Area Under Curve Cohort Studies Disease-Free Survival Fatal Outcome Intention to Treat Analysis Organizational Culture Postoperative Care Clinical Audit National Institute for Occupational Safety and Health (U.S.)

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Named Groups Health Care

Sirolimus Immunosuppressive Agents Safety Tacrolimus Cyclosporine Mycophenolic Acid Kidney Transplantation Immunosuppression Graft Rejection Treatment Outcome Calcineurin Azathioprine Safety Management Drug Therapy, Combination Patient Safety Graft Survival Time Factors Immune Tolerance Transplantation, Homologous Antilymphocyte Serum Liver Transplantation Cyclosporins Drug Substitution Dose-Response Relationship, Drug Follow-Up Studies T-Lymphocytes Retrospective Studies Double-Blind Method Prednisolone Polyenes Transplantation Heart Transplantation Islets of Langerhans Transplantation Drug Administration Schedule TOR Serine-Threonine Kinases Prospective Studies Drug Monitoring Lymphangioleiomyomatosis Antibodies, Monoclonal Food Safety Lymphocyte Activation Angiomyolipoma Adrenal Cortex Hormones Mice, Inbred BALB C Kidney Administration, Oral Equipment Safety Organ Transplantation Immunocompromised Host Creatinine Anemia, Aplastic Recurrence Glucocorticoids Methylprednisolone Anti-Inflammatory Agents Prednisone Mice, Inbred C57BL T-Lymphocytes, Regulatory Postoperative Complications Coronary Restenosis Pilot Projects Lymphangiomyoma Cells, Cultured Disease Models, Animal Injections, Intraocular Biopsy Steroids Cell Proliferation Cyclophosphamide Drug Interactions Antibodies, Monoclonal, Humanized Drug-Eluting Stents Graft vs Host Disease Consumer Product Safety Interleukin-10 Drug Combinations Neoplasms Antibiotics, Antineoplastic Clinical Trials as Topic Randomized Controlled Trials as Topic Antineoplastic Agents Cytokines Spleen Indoleamine-Pyrrole 2,3,-Dioxygenase Glomerular Filtration Rate Amino Acid Isomerases Methotrexate Chyle Lymphocytes Cardiovascular Agents Interleukin-2 Transplantation Immunology Skin Transplantation Stents Tissue Donors Flow Cytometry Propylene Glycols Chronic Disease Living Donors Acute Disease

No FAQ available that match "safety and efficacy of sirolimus as immunosuppressive"